You can access the annual and quarterly cash flow statements of Drugs Made In America Acquisition Corp to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---56.11K
---106.66K
---251.24K
Net income from continuing operations
--2.18M
--2.29M
--1.25M
Other non-cash items
--31.00K
---10.90K
--94.57K
Change in working capital
--176.59K
--36.16K
---14.89K
-Change in prepaid expenses
--21.43K
--21.19K
---70.10K
-Change in payables and accrued expense
--155.17K
--14.97K
--55.20K
Cash from non-recurring investing activities
Cash from operating activities
---56.11K
---106.66K
---251.24K
Investing cash flow
Net cash flow from investment products
--0.00
--0.00
---231.15M
Net cash flow from other investing activities
--0.00
----
----
Cash from non-current investing activities
Net cash flow from investing activities
--0.00
--0.00
---231.15M
Financing cash flow
Cash flow from continuous financing activities
--56.00K
--106.55K
--231.40M
Net cash flow from debt Issuance/repayment
--0.00
--0.00
---900.00K
Net cash flow from other financing activities
--56.00K
--106.55K
--232.30M
Net cash from non-recurrent financing activities
Net cash from financing activities
--56.00K
--106.55K
--231.40M
Net cash flow
Beginning cash balance
--822.00
--923.00
--1.35K
Current period cash flow changes
---105.00
---101.00
---428.00
Ending cash balance
--717.00
--822.00
--923.00
Free cash flow
---56.11K
---106.66K
---251.24K
Currency unit
USD
USD
USD
Audit opinions
--
--
--
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.